Verification evidence is still being completed.
PDF / print export
Mainz Biomed
Mainz, Germany
- Verified lead
- Guido Baechler
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Cancer Screening, Molecular Diagnostics, Colorectal Cancer, Pancreatic Cancer, and Biomarker Testing
- Review cycle
- May 2026
- Full address
- Robert-Koch-Strasse 50, 55129 Mainz, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Mainz Biomed contact page confirming the Mainz address.
- Editorial note
- Mainz Biomed is published because official company materials confirm current leadership, Mainz operating address, and a real molecular-diagnostics platform.
Cancer Screening, Molecular Diagnostics, Colorectal Cancer, Pancreatic Cancer, and Biomarker Testing
Official leadership disclosure, Official Mainz address disclosure, Diagnostics platform claim
Mainz Biomed is published because official company materials confirm current leadership, Mainz operating address, and a real molecular-diagnostics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Mainz, Germany
Mainz Biomed
Cancer Screening, Molecular Diagnostics, Colorectal Cancer, Pancreatic Cancer, and Biomarker Testing · Diagnostics platform
Mainz Biomed runs cancer screening test development, molecular diagnostics programs, and biomarker platform development in Mainz, Germany.
- Lead
- Guido Baechler (verified ↗)
- Address
- Robert-Koch-Strasse 50, 55129 Mainz, Germany (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- Cancer Screening Test Development · Molecular Diagnostics Programs · Biomarker Platform Development
- Founded
- 2020
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Guido Baechler
Chief Executive Officer
Full addressRobert-Koch-Strasse 50, 55129 Mainz, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Diagnostics platform
Mainz, Germany. Cancer Screening, Molecular Diagnostics, Colorectal Cancer, Pancreatic Cancer, and Biomarker Testing. Review completed on 22 Mar 2026.
German molecular-diagnostics oversight
Official leadership disclosure, Official Mainz address disclosure, Diagnostics platform claim
Cancer Screening, Molecular Diagnostics, Colorectal Cancer, Pancreatic Cancer, and Biomarker Testing
Mainz Biomed is published because official company materials confirm current leadership, Mainz operating address, and a real molecular-diagnostics platform.
Editorial note
Mainz Biomed is published because official company materials confirm current leadership, Mainz operating address, and a real molecular-diagnostics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cancer Screening Test Development
Molecular Diagnostics Programs
Biomarker Platform Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Biomarker workflow systems
Molecular testing infrastructure
Diagnostics program management tools
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Mainz Biomed located?
- Mainz Biomed operates from Robert-Koch-Strasse 50, 55129 Mainz, Germany, Mainz, Germany.
- Who runs Mainz Biomed?
- Mainz Biomed is led by Guido Baechler, Chief Executive Officer. Verified 22 Mar 2026.
- What does Mainz Biomed do?
- Mainz Biomed runs cancer screening test development, molecular diagnostics programs, and biomarker platform development in Mainz, Germany. Core capabilities: Cancer Screening Test Development, Molecular Diagnostics Programs, Biomarker Platform Development.
Editorial context
Related technical briefs
Briefs that name Mainz as a covered market or city.